Evidence map›Paper›PMID 42585315›Full record

ArticleScience advances2026

GNPs-pIL-4 reprograms macrophage polarization and activates the OSM/GSNOR/ENG axis to improve angiogenesis in ischemic limbs.

Peng Zhang, Jinman Zhuang, Yizhou Hao, Xiangrui Zhu, Hongbiao Liang, Guizimeng Hu, Peiyi Li, Yuwei Song, Qijia Liu, Guangxin Yang and 12 more

Abstract read
In one paragraph

Article in Science advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Peng ZhangDepartment of Integration of Chinese and Western Medicine, School of Basic Medical Sciences, Department of Interventional Radiology and Vascular Surgery, Third Hospital, Peking University, Beijing, China.ORCID 0000-0001-7042-8000
Jinman ZhuangDepartment of Integration of Chinese and Western Medicine, School of Basic Medical Sciences, Department of Interventional Radiology and Vascular Surgery, Third Hospital, Peking University, Beijing, China.ORCID 0009-0004-7367-808X
Yizhou HaoMoxi Technology, Guangzhou, China.ORCID 0009-0004-2634-7819
Xiangrui ZhuDepartment of Integration of Chinese and Western Medicine, School of Basic Medical Sciences, Department of Interventional Radiology and Vascular Surgery, Third Hospital, Peking University, Beijing, China.ORCID 0009-0001-2281-3825
Hongbiao LiangDepartment of Integration of Chinese and Western Medicine, School of Basic Medical Sciences, Department of Interventional Radiology and Vascular Surgery, Third Hospital, Peking University, Beijing, China.ORCID 0009-0002-6271-9371
Guizimeng HuDepartment of Integration of Chinese and Western Medicine, School of Basic Medical Sciences, Department of Interventional Radiology and Vascular Surgery, Third Hospital, Peking University, Beijing, China.ORCID 0009-0001-5508-6513
Peiyi LiDepartment of Integration of Chinese and Western Medicine, School of Basic Medical Sciences, Department of Interventional Radiology and Vascular Surgery, Third Hospital, Peking University, Beijing, China.ORCID 0009-0005-5217-8139
Yuwei SongDepartment of Integration of Chinese and Western Medicine, School of Basic Medical Sciences, Department of Interventional Radiology and Vascular Surgery, Third Hospital, Peking University, Beijing, China.ORCID 0000-0002-4956-227X
Qijia LiuDepartment of Integration of Chinese and Western Medicine, School of Basic Medical Sciences, Department of Interventional Radiology and Vascular Surgery, Third Hospital, Peking University, Beijing, China.ORCID 0000-0003-3867-3318
Guangxin YangDepartment of Integration of Chinese and Western Medicine, School of Basic Medical Sciences, Department of Interventional Radiology and Vascular Surgery, Third Hospital, Peking University, Beijing, China.ORCID 0000-0002-9540-8089
Tianqi ChenDepartment of Integration of Chinese and Western Medicine, School of Basic Medical Sciences, Department of Interventional Radiology and Vascular Surgery, Third Hospital, Peking University, Beijing, China.ORCID 0000-0002-8762-9682
Xinmei HuoDepartment of Integration of Chinese and Western Medicine, School of Basic Medical Sciences, Department of Interventional Radiology and Vascular Surgery, Third Hospital, Peking University, Beijing, China.ORCID 0009-0000-8149-8151
Kai SunTasly Microcirculation Research Center, Peking University Health Science Center, Beijing, China.ORCID 0009-0007-3103-8975
Li YanTasly Microcirculation Research Center, Peking University Health Science Center, Beijing, China.ORCID 0009-0006-1299-8105
Chun-Shui PanTasly Microcirculation Research Center, Peking University Health Science Center, Beijing, China.ORCID 0009-0005-7587-0048
Qihua HeStar Key Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing, China.ORCID 0009-0009-7381-7277
Kuangda LuInstitute of Advanced Clinical Medicine, Peking University, Beijing, China.ORCID 0000-0003-3839-3404
Yang ZhaoDepartment of Laboratory Medicine, Peking University Third Hospital, Beijing, China.ORCID 0000-0001-6521-1851
Jing-Yan HanDepartment of Integration of Chinese and Western Medicine, School of Basic Medical Sciences, Department of Interventional Radiology and Vascular Surgery, Third Hospital, Peking University, Beijing, China.ORCID 0000-0002-2286-8076
Tianrun LiDepartment of Integration of Chinese and Western Medicine, School of Basic Medical Sciences, Department of Interventional Radiology and Vascular Surgery, Third Hospital, Peking University, Beijing, China.ORCID 0000-0002-1947-640X
Jian-Hao ChenInternational Center for Quantum Materials, School of Physics, Peking University, Beijing, China.ORCID 0000-0002-9485-1759
Juan FengDepartment of Integration of Chinese and Western Medicine, School of Basic Medical Sciences, Department of Interventional Radiology and Vascular Surgery, Third Hospital, Peking University, Beijing, China.ORCID 0000-0003-0174-4784

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Therapeutic angiogenesis based on gene therapies is a potential peripheral artery disease (PAD) treatment yet needs a more stable, efficient, and high-affinity delivery vector and an optimized delivery strategy. Here, we engineered three-dimensional graphene nanoparticles modified with folic acid and polyethyleneimine for macrophage-specific delivery of interleukin-4 plasmids (pIL-4), forming GNPs-pIL-4 for local intramuscular injection. GNPs-pIL-4 had uniform size, positive surface charge, and strong nucleic acid loading capacity (

Indexed as

AngiogenesisIschemiaMacrophagesNeovascularization, PhysiologicOncostatin MAnimalsCell PolarityGenetic TherapyHumansMacrophage ActivationMiceNanoparticlesPlasmidsOncostatin M

Identifiers

PMID42585315
PMCPMC13464477

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.